Premium
P12.07: Evaluation of adverse events of amniocentesis during transabdominal amnioinfusion
Author(s) -
Nagai R.,
Takahashi Y.,
Yasumi S.,
Katsura D.,
Asai K.,
Matsui M.,
Chiaki R.,
Iwagaki S.,
Furuhashi M.,
Kawabata I.
Publication year - 2019
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.20993
Subject(s) - medicine , amnioinfusion , amniocentesis , adverse effect , amniotic fluid , cannula , obstetrics , fetus , oligohydramnios , polyhydramnios , hematoma , surgery , anesthesia , pregnancy , prenatal diagnosis , genetics , biology
To evaluate adverse events(AE) of amniocentesis(AC) during trans abdominal amnioinfusion (TAA). Methods We performed AC for several indications for TAA. The puncture site was determined under ultrasonic guidance, and a puncture was performed with a 21 to 23-gauge percutaneous trans-hepatic cholangiography needle. Warm saline was infused via gravity until sufficient amniotic fluid cavity is confirmed. And we used Common Terminology Criteria for Adverse Events (CTCAE) to evaluate the AE of TAA for fetal treatment and grading was set from 1 to 5. First, using these criteria for AE, the AE scores of a series of our single facility (tertiary perinatal institution) of TAA for 126 cases with 313 procedures those could be evaluated AE after procedures were analyzed. Furthermore, we examined AE for each number of punctures for cases with severe AE than grade 3. Evaluation of adverse events of amniocentesis during transabdominal amnioinfusion Ryuhei Nagai, Yuichiro Takahashi, Shunsuke Yasumi, Daisuke Katsura, Kazuhiko Asai, Masako Koike, Rika Chiaki, Shigenori Iwagaki, Madoka Huruhashi, Ichiro Kawabata Department of Obstetrics , Kochi Health Sciences Center, Japan